UBS Group »

Acasti Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $122k 26k 4.63

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Acasti Pharma

HPM Partners
Nantahala Capital Management
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Jane Street
Renaissance Technologies
Citadel Advisors
Connective Capital Management
Birchview Capital
Diametric Capital
XTX Topco
UBS Group
Kestra Private Wealth Services
Oppenheimer & Co

View all funds holding Acasti Pharma